rel-(1R,2S,5R)-5-Methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol

Catalog No. :
ACKLTZ382
CAS No. :
50373-36-9
Molecular Formula :
C10H18O
Molecular Weight :
154.25

IUPAC Name:(1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol

rel-(1R,2S,5R)-5-Methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,2S,5R)-5-Methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol
IUPAC Name(1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol
Molecular FormulaC10H18O
Molecular Weight154.25
SMILESO[C@H]1[C@H](C(C)=C)CC[C@@H](C)C1
InChI KeyZYTMANIQRDEHIO-KXUCPTDWSA-N
SynonymAS-10358 | EINECS 256-557-7 | Isopulegol | (1R,3R,4S)-P-METH-8-EN-3-OL | 5-Methyl-2-(1-methylethenyl)cyclohexanol, (1R-(1alpha,2beta,5alpha))- | GTPL2462 | NVG8YK55NL | p-8(9)-Menthen-3-ol | Cyclohexanol, 5-methyl-2-(1-methylethenyl)-, (1R,2S,5R)- | DTXSI
CAS No.50373-36-9
PubChem CID170833

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKLTZ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKLTZ382 route product structure diagram
    ACKLTZ38250373-36-9
Inquiry

2. ACKLTZ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACKLTZ382 route product structure diagram
    ACKLTZ38250373-36-9
Inquiry

Comments (0)